GIM
FENC icon

Granahan Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History

Granahan Investment Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-217,295
Closed -$1.35M – 198
2021
Q1 		$1.35M Sell
217,295
-177,515
-45% -$1.34M 0.03% 179
2020
Q4 		$2.94M Sell
394,810
-36,660
-8% -$279K 0.07% 156
2020
Q3 		$2.62M Buy
431,470
+186,093
+76% +$1.31M 0.09% 140
2020
Q2 		$2.05M Sell
245,377
-24,832
-9% -$185K 0.07% 154
2020
Q1 		$1.6M Sell
270,209
-115,671
-30% -$754K 0.09% 147
2019
Q4 		$2.5M Sell
385,880
-70,099
-15% -$377K 0.12% 129
2019
Q3 		$2.19M Buy
455,979
+16,896
+4% +$74.6K 0.12% 135
2019
Q2 		$1.76M Buy
439,083
+28,151
+7% +$119K 0.09% 150
2019
Q1 		$1.99M Buy
410,932
+45,999
+13% +$302K 0.11% 151
2018
Q4 		$2.33M Buy
364,933
+141,810
+64% +$991K 0.16% 123
2018
Q3 		$1.83M Buy
223,123
+166,121
+291% +$1.54M 0.1% 159
2018
Q2 		$595K Buy
57,002
+9,626
+20% +$114K 0.04% 190
2018
Q1 		$573K Sell
47,376
-11,668
-20% -$110K 0.04% 181
2017
Q4 		$592K Buy
59,044
+9,451
+19% +$94.3K 0.05% 184
2017
Q3 		$550K Buy
+49,593
New +$576K 0.05% 167

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Granahan Investment Management's FENC Position: Q2 2021 in Review

Granahan Investment Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2021, closing a stake of 217,295 shares — an estimated $1.35M sold.

Granahan Investment Management first reported a position in FENC in Q3 2017 and held it in 15 quarters. The position peaked at $2.94M in Q4 2020. 39 funds tracked by Wall St. Rank hold FENC as of Q2 2021.

  • Granahan Investment Management reported no remaining Fennec Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Granahan Investment Management sold 217,295 Fennec Pharmaceuticals shares in Q2 2021, an estimated $1.35M.
  • Granahan Investment Management first reported a position in Fennec Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Granahan Investment Management's Fennec Pharmaceuticals position peaked at $2.94M in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2021.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.